CD47-signal regulatory protein- (SIRP ) interactions form a barrier for antibody-mediated tumor cell destruction-Reference-Cited by-同舟云学术

CD47-signal regulatory protein- (SIRP ) interactions form a barrier for antibody-mediated tumor cell destruction

Published:2011-10-31 Issue:45 Volume:108 Page:18342-18347
ISSN:0027-8424
Container-title:Proceedings of the National Academy of Sciences
language:en
Short-container-title:Proceedings of the National Academy of Sciences

Author:

Zhao X. W.,van Beek E. M.,Schornagel K.,Van der Maaden H.,Van Houdt M.,Otten M. A.,Finetti P.,Van Egmond M.,Matozaki T.,Kraal G.,Birnbaum D.,van Elsas A.,Kuijpers T. W.,Bertucci F.,van den Berg T. K.

Publisher

Proceedings of the National Academy of Sciences

Subject

Multidisciplinary

Reference37 articles.

1. Renaissance of cancer therapeutic antibodies

2. Monoclonal Antibodies in Cancer Therapy: 25 Years of Progress

3. A Mechanistic Perspective of Monoclonal Antibodies in Cancer Therapy Beyond Target-Related Effects

4. Inhibitory Fc receptors modulate in vivo cytoxicity against tumor targets

5. Trastuzumab causes antibody-dependent cellular cytotoxicity–mediated growth inhibition of submacroscopic JIMT-1 breast cancer xenografts despite intrinsic drug resistance

Cited by 253 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dual-Action Protein-siRNA Conjugates for Targeted Disruption of CD47-Signal Regulatory Protein α Axis in Cancer Therapy;ACS Nano;2024-08-08

2. Development and evaluation of a human CD47/HER2 bispecific antibody for Trastuzumab-resistant breast cancer immunotherapy;Drug Resistance Updates;2024-05

3. Tumor-expressed SPPL3 supports innate anti-tumor immune responses;2024-04-28

4. Disruption of CD47-SIRPα signaling restores inflammatory function in tumor-associated myeloid-derived suppressor cells;iScience;2024-04

5. HER2 Prognostic Significance and Therapeutic Implications in Gastric Cardia Adenocarcinoma: Insights from Multi-Omics Profiling;2024-03-06